Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis

C Hermans, M Petrek, V Kolek, B Weynand, T Pieters, M Lambert, A Bernard

. 2001 ; 18 (3) : 507-14.

Language English Country Denmark

Document type Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc13020102

Grant support
NI5275 MZ0 CEP Register

To test the hypothesis that sarcoidosis is associated with an intravascular leakage of lung epithelium secretory proteins, the occurrence and determinants in serum of sarcoid patients of CC16, a small size and readily diffusible lung-specific protein of 16 kDa secreted by bronchiolar Clara cells, was investigated. CC16 was measured by a sensitive latex immunoassay in the serum of 117 patients with established sarcoidosis and of 117 healthy subjects matched for age, sex and smoking status. Stepwise regression analysis was used to identify extrapulmonary variables of CC16 changes in serum. These changes were then compared with biochemical and cellular parameters in bronchoalveolar lavage fluid (BALF) as well as with the number of CC16 immunostaining cells on bronchial or pulmonary biopsy samples. CC16 concentration in serum of sarcoid patients was significantly increased, compared to their matched controls (25.9 +/- 16.2 versus 13.9 +/- 5.2 microg x L(-1)). In nonsmoking patients without significant renal impairment, CC16 in serum increased with the severity of the chest radiograph and computed tomography changes, and was on average 50-100% higher when parenchymal involvement was present. Sarcoid patients had, however, normal levels of CC16 in BALF and an unchanged number of CC16-immunopositive cells in lung biopsy samples, suggesting that an increased secretion of CC16 in the sarcoid lung is very unlikely, and that the elevation of CC16 in sarcoidosis results from an increased intravascular leakage of the protein across the air-blood barrier. The present study suggests that CC16 in serum might provide a useful tool to noninvasively evaluate the damage and increased permeability to proteins of the air-blood barrier associated with sarcoidosis.

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13020102
003      
CZ-PrNML
005      
20130528154910.0
007      
ta
008      
130528s2001 dk a f 000 0|eng||
009      
AR
035    __
$a (PubMed)11589348
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a dk
100    1_
$a Hermans, C. $u Industrial Toxicology and Occupational Medicine Unit, Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Belgium.
245    10
$a Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis / $c C Hermans, M Petrek, V Kolek, B Weynand, T Pieters, M Lambert, A Bernard
504    __
$a Literatura
520    9_
$a To test the hypothesis that sarcoidosis is associated with an intravascular leakage of lung epithelium secretory proteins, the occurrence and determinants in serum of sarcoid patients of CC16, a small size and readily diffusible lung-specific protein of 16 kDa secreted by bronchiolar Clara cells, was investigated. CC16 was measured by a sensitive latex immunoassay in the serum of 117 patients with established sarcoidosis and of 117 healthy subjects matched for age, sex and smoking status. Stepwise regression analysis was used to identify extrapulmonary variables of CC16 changes in serum. These changes were then compared with biochemical and cellular parameters in bronchoalveolar lavage fluid (BALF) as well as with the number of CC16 immunostaining cells on bronchial or pulmonary biopsy samples. CC16 concentration in serum of sarcoid patients was significantly increased, compared to their matched controls (25.9 +/- 16.2 versus 13.9 +/- 5.2 microg x L(-1)). In nonsmoking patients without significant renal impairment, CC16 in serum increased with the severity of the chest radiograph and computed tomography changes, and was on average 50-100% higher when parenchymal involvement was present. Sarcoid patients had, however, normal levels of CC16 in BALF and an unchanged number of CC16-immunopositive cells in lung biopsy samples, suggesting that an increased secretion of CC16 in the sarcoid lung is very unlikely, and that the elevation of CC16 in sarcoidosis results from an increased intravascular leakage of the protein across the air-blood barrier. The present study suggests that CC16 in serum might provide a useful tool to noninvasively evaluate the damage and increased permeability to proteins of the air-blood barrier associated with sarcoidosis.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a albuminy $x analýza $7 D000418
650    02
$a biologické markery $7 D015415
650    12
$a alveolokapilární membrána $7 D015824
650    02
$a bronchoalveolární lavážní tekutina $x chemie $7 D001992
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a imunoenzymatické techniky $7 D007124
650    02
$a počet lymfocytů $7 D018655
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    12
$a proteiny $x analýza $7 D011506
650    02
$a regresní analýza $7 D012044
650    02
$a proteiny vázající retinol $x analýza $7 D012177
650    12
$a plicní sarkoidóza $x krev $x patofyziologie $7 D017565
650    12
$a uteroglobin $7 D014598
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Petřek, Martin, $d 1963- $7 jn20000401972 $u Department of Immunology, Palacky University, Olomouc, Czech Republic
700    1_
$a Kolek, Vítězslav, $d 1953-2020 $7 jn20000401390 $u Department of Respiratory Medicine, Palacky University, Olomouc, Czech Republic
700    1_
$a Weynand, B.
700    1_
$a Pieters, T.
700    1_
$a Lambert, M.
700    1_
$a Bernard, A.
773    0_
$t The European respiratory journal $x 0903-1936 $g Roč. 18, č. 3 (2001), s. 507-14 $p Eur Respir J $w MED00001660
773    0_
$p Eur Respir J $g 18(3):507-14, 2001 Sep $x 0903-1936
910    __
$a ABA008 $b B 1607 $y 3 $z 0
990    __
$a 20130528135955 $b ABA008
991    __
$a 20130528155246 $b ABA008
999    __
$a ok $b bmc $g 983471 $s 818448
BAS    __
$a 3
BMC    __
$a 2001 $b 18 $c 3 $d 507-14 $i 0903-1936 $m The European respiratory journal $x MED00001660 $n Eur Respir J
GRA    __
$a NI5275 $p MZ0
LZP    __
$a 2013-05/dpbo

Find record

Citation metrics

Archiving options